BioNTech SE (BNTX)
89.55
-2.44
(-2.65%)
USD |
NASDAQ |
May 15, 16:00
89.10
-0.45
(-0.50%)
After-Hours: 20:00
BioNTech Shareholders Equity (Quarterly) : 21.54B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novavax, Inc. | -144.76M |
| Moderna, Inc. | 7.408B |
| Biodexa Pharmaceuticals Plc | -- |
| GSK Plc | 23.54B |
| Merck & Co., Inc. | 45.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.28B |
| Total Liabilities (Quarterly) | 2.738B |
| Debt to Equity Ratio | 0.0162 |
| Current Ratio | 8.800 |
| Net Debt Paydown Yield | -0.08% |